Navigation Links
HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues
Date:1/14/2014

Looking Statements
This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management.  All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to commercialization of the HeartWare® Ventricular Assist System in the U.S. and around the world, initiation and progress of clinical trials and post-approval studies, regulatory status and indication expansion, research and development activities and business strategies.  Management believes that these forward-looking statements are reasonable as and when made.  However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made.  HeartWare does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.  HeartWare may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events could differ materially from those disclosed in the forward-looking statements.  Forward-looking statements are subject to a number of risks and uncertainties, including without limitation those described in Part I, Item 1A. "Risk Factors" in HeartWare's Annual Report on Form 10-K filed with the Securities and Exchange Commission.  HeartWare may update risk factors from time to time in Part II, Item 1A "Risk Factors" in Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, or other filings with the Securities and Exchange Commission.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email:

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
2. Heartware Schedules First Quarter Conference Call And Webcast
3. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
4. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
5. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
6. HeartWare Names Peter F. McAree Chief Financial Officer
7. HeartWare Schedules Second Quarter Conference Call And Webcast
8. HeartWare Completes Acquisition Of World Heart Corporation
9. HeartWare Reports Second Quarter 2012 Results
10. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
11. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015  Legal-Bay LLC, The Lawsuit ... Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for ... According to PBR, Boehringer submitted a supplemental new ... that Pradaxa will be approved for the prophylaxis ... (PE) for patients who have undergone a primary ...
(Date:4/20/2015)... , April 20, 2015 Research published today ... of Sciences (PNAS) demonstrates that technology invented ... Casey Eye Institute can improve the ... Optical coherence tomography (OCT) angiography could largely replace ... diseases. OHSU researchers found that OCT ...
(Date:4/20/2015)... BILLERICA, Mass. , April 20, 2015 /PRNewswire/ ... tools for cell metabolism research, introduces the XFp ... a unique real-time assay on live cells that ... one-hour test measures both the mitochondrial and glycolytic ... values with metabolic activity under stressed conditions, induced ...
Breaking Medicine Technology:Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3Study shows new technology may improve management of leading causes of blindness 2Study shows new technology may improve management of leading causes of blindness 3Study shows new technology may improve management of leading causes of blindness 4Study shows new technology may improve management of leading causes of blindness 5New XFp Cell Energy Phenotype Test Determines Metabolic Potential 2New XFp Cell Energy Phenotype Test Determines Metabolic Potential 3
... As previously announced, primary endpoint not met; ... with ERBITUX,-, NEW YORK, April 16, 2007 ... Company today,announced detailed results from the EPIC ... trial - comparing ERBITUX(R),(Cetuximab) plus irinotecan to ...
... WIRE)--Apr 17, 2007 - Curis, Inc.,(NASDAQ:CRIS), a ... primarily for cancer treatment, today announced that ... the 98th Annual Meeting,of the American Association ... also disclosed that its April 2005 discovery,collaboration ...
Cached Medicine Technology:Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 2Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 3Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 4
(Date:4/21/2015)... Lifeguard Master is out with their new ... listed on the Lifeguard Master website and are in stock. ... want a quality and flexible product during their rescue efforts. ... color Spider Straps are some of the most popular items ... sturdy, heavy nylon” , The Spider Straps are rated superior ...
(Date:4/21/2015)... Dr. Zain Kadri, a Beverly Hills plastic surgery ... a close look at the rise of plastic surgery among ... both Dr. Kadri’s website and RedOrbit , is titled ... of the Selfie.” According to Dr. Kadri, who offers exceptional ... of A-list patients, the trend of taking selfies has been ...
(Date:4/21/2015)... TX (PRWEB) April 21, 2015 ... from a prestigious Illinois university for a second ... units (NICUs) more conducive to newborn infants’ cognitive ... top three NICU problems we have identified through ... care professionals,” said George Hutchinson, Invictus Medical’s Chief ...
(Date:4/20/2015)... April 20, 2015 Construction has ... in Stuarts Draft, an independent, nonprofit community hospital ... Waynesboro, Virginia. The project was an ongoing collaboration ... Draft facility is expected to provide additional employment ... Stuarts Draft Highway, the new facility features physician ...
(Date:4/20/2015)... NAPW honors Suzanne ... the Year. Ms. Webb is recognized with this prestigious ... networking organization of professional women in the country, spanning ... Professional Women is a powerfully vibrant networking community with ... “We are like an Angie’s List for surgeons and ...
Breaking Medicine News(10 mins):Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 2Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 3Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 4Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:National Association of Professional Women Announces Suzanne Webb, Chief Executive Officer at Exclusive Surgeries Network, LLC, a 2015 Professional Woman of the Year 2
... cause employers to abandon benefits, study finds , , FRIDAY, April ... insurance for employees increased more for small U.S. businesses than ... small businesses have not stopped offering the benefit, a new ... Corp., of more than 2,500 small, medium and large companies ...
... delve into some of the crucial issues surrounding death by ... in the joint University of Adelaide/IMVS Centre for Neurological Diseases, ... brain and the reasons why brain tumours or strokes become ... brain works, and this new research will help to unlock ...
... 2008 Companies align,commercial and portfolio management employees ... sales volume of $10 to 20 billion, on ... commercialization team along,with approximately eight portfolio managers. At ... four to three, commercial to,portfolio management staff, according ...
... CHAPEL HILL Young children who lead inactive lifestyles are ... heart disease, with that degree of danger emerging as early ... researchers at the University of North Carolina at Chapel Hill. ... access journal Dynamic Medicine, looked at a group of children ...
... 54 million American,adults have prediabetes, but many of ... and all of its health complications thanks to ... Optimal Health,Company. It is estimated that 60 percent ... choices., "When someone is pre-diabetic, they don,t ...
... but not mother,s, weight and elevated enzymes , , THURSDAY, ... early-onset obesity are at increased risk for elevated liver ... , Researchers evaluated 1,732 children, average age 42, of ... of families in Framingham, Mass. The researchers found that ...
Cached Medicine News:Health News:Small Firms Shoulder Burden of Increasing Health Costs 2Health News:Unlocking mysteries of brain cancer, stroke 2Health News:Early-stage Commercialization Success: Pharma Companies Adjust Resources in Light of Industry Changes 2Health News:Inactive kids face 6-fold risk of heart disease by teen years, study finds 2Health News:Kronos Optimal Health Company Aims to Stop Diabetes Before It Starts 2Health News:Dads' Early-Onset Obesity Linked to Liver Disease in Kids 2
Aluminum english and metric ruler. 1 3/8 inche wide....
At 14 cm point, ruler is bent at 90 degrees angle brought to a blunt point at 15 cm....
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: